When there are bargains on stocks with long-term appeal, astute investors make sure to get a few shares while the getting is good. And if you're looking for exposure to growth, the stocks listed on the Nasdaq-100 Index -- which is part of the Nasdaq Composite -- is a good place to start. In that vein, let's discuss a pair of monster growth stocks that are worth buying hand-over-fist right now.

Image source: Getty Images.

In truth, Moderna (NASDAQ: MRNA) is a bit of a contrarian purchase at the moment as nobody expects it to one-up its 2022 top line of nearly $19 billion now that sales of its coronavirus vaccine are expected to fall to as low as $5 billion in 2023. And there's little to suggest that demand for its shots will surge to reach the heights of the last couple of years ever again.

Continue reading

Source Fool.com